Surovatamig
D7409C00001
Phase 3 small_molecule active
Quick answer
Surovatamig for Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active